Paper Details

  1. Home
  2. Paper Details

Time-to-effect with darifenacin in overactive bladder: a pooled analysis.

Author: EgermarkMathias, FooteJenelle, KhullarVik, SeifuYodit

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Darifenacin, a medication for overactive bladder (OAB), was found to be effective as early as 6 to 8 days after starting treatment. Both 7.5 mg and 15 mg doses significantly reduced OAB symptoms throughout the study, including micturition frequency, incontinence episodes, and urgency.
Paper Details　
Original Abstract of the Article :
INTRODUCTION AND HYPOTHESIS: This study was conducted to assess time-to-effect with darifenacin in patients with overactive bladder (OAB). METHODS: Efficacy and safety data were pooled from 1,059 patients (19-88 years, 85% women) randomized to darifenacin 7.5 or 15 mg once daily or matched placebo ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/s00192-011-1522-0

データ提供：米国国立医学図書館（NLM）

Darifenacin: A Swift Oasis for Overactive Bladder

Overactive bladder (OAB) is a common condition that can significantly impact quality of life. This research investigates the time-to-effect of darifenacin, a medication used to treat OAB, by analyzing data from a pooled analysis of multiple clinical trials. The study aims to determine how quickly darifenacin provides relief from OAB symptoms.

Darifenacin: A Quick Refreshment in the Desert of OAB

The results demonstrate that darifenacin effectively reduces OAB symptoms, with significant improvements observed as early as days 6-8 after treatment initiation. This rapid onset of effect is a valuable benefit for patients seeking quick relief from the discomfort of OAB. It's like finding a refreshing oasis in the midst of a scorching desert, providing instant relief from thirst and discomfort.

Finding Relief in the Desert of OAB

This research underscores the potential of darifenacin to provide rapid and sustained relief for individuals suffering from OAB. It's a reminder that even in the midst of a challenging condition, there are often ways to find relief and improve quality of life. Like a camel seeking water in the desert, individuals with OAB can find solace and support in appropriate treatment options.

Dr. Camel's Conclusion

Darifenacin offers a swift and refreshing oasis in the desert of overactive bladder, providing rapid relief for those seeking solace from uncomfortable symptoms. This research highlights the importance of exploring treatment options that provide quick and lasting relief for individuals navigating the challenges of OAB.

Date :
  1. Date Completed 2012-03-20
  2. Date Revised 2021-10-20
Further Info :

Pubmed ID

22006023

DOI: Digital Object Identifier

10.1007/s00192-011-1522-0

Related Literature

Article Analysis
・Effects of darifenacin
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.